BioCentury
ARTICLE | Financial News

Acceleron sets IPO range

September 7, 2013 12:58 AM UTC

Acceleron Pharma Inc. (Cambridge, Mass.) amended its IPO and now plans to sell 4.7 million shares at $13-$15. At the $14 midpoint, the company would raise $65.1 million and be valued at $359.9 million. Partner Celgene Corp. (NASDAQ:CELG) also has agreed to purchase $10 million in shares in a concurrent private placement. Acceleron filed to raise up to $74.8 million in August. Citigroup; Leerink; Piper Jaffray; and JMP Securities are underwriters. ...